| Message: | Letrozoles are non suicidal Aromatase Inhibitors, belonging to the third generation of aromatase inhibitors.
They are administered orally and hold the approval of the Food and Drug Administration of the United States (FDA) for use in treating two particular kinds of breast cancer:
One is the case when hormone receptor positive breast cancer develops locally or is contracted through metastatis.
The other is a similar case but when the cancer is of the estrogen receptor unknown category.
Letrazole Application:
1). The anti-estrogen action of Femara has been shown to be useful in pretreatment for termination of pregnancy, in combination with misoprostol. It can be used in place of mifepristone, which is expensive and unavailable in many countries.
|
my account
